Advertisement

Usefulness of Neutrophil/Lymphocyte Ratio As Predictor of New-Onset Atrial Fibrillation After Coronary Artery Bypass Grafting

Published:December 07, 2009DOI:https://doi.org/10.1016/j.amjcard.2009.09.007
      The neutrophil/lymphocyte (N/L) ratio integrates information on the inflammatory milieu and physiologic stress. It is an emerging marker of prognosis in patients with cardiovascular disease. We investigated the relation between the N/L ratio and postoperative atrial fibrillation (AF) in patients undergoing coronary artery bypass grafting. In a prospective cohort study, 275 patients undergoing nonemergency coronary artery bypass grafting were recruited. Patients with previous atrial arrhythmia or requiring concomitant valve surgery were excluded. The N/L ratio was determined preoperatively and on postoperative day 2. The study end point was AF lasting >30 seconds. Patients who developed AF (n = 107, 39%) had had a greater preoperative N/L ratio (median 3.0 vs 2.4, p = 0.001), but no differences were found in the other white blood cell parameters or C-reactive protein. The postoperative N/L ratio was greater in patients with AF (day 2, median 9.2 vs 7.2, p <0.001), and in multivariate models, a greater postoperative N/L ratio was independently associated with a greater incidence of AF (odds ratio 1.10 per unit increase, p = 0.003: odds ratio for N/L ratio >10.14 [optimal postoperative cutoff in our cohort], 2.83 per unit, p <0.001). Elevated pre- and postoperative N/L ratios were associated with an increased occurrence of AF after coronary artery bypass grafting. In conclusion, these results support an inflammatory etiology in postoperative AF but suggest that other factors are also important.
      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gedikli O.
        • Dogan A.
        • Altuntas I.
        • Altinbas A.
        • Ozaydin M.
        • Akturk O.
        • Acar G.
        Inflammatory markers according to types of atrial fibrillation.
        Int J Cardiol. 2007; 120: 193-197
        • Anderson J.L.
        • Maycock A.
        • Lappe D.L.
        • Crandall B.G.
        • Horne B.D.
        • Bair T.L.
        • Morris S.R.
        • Li Q.
        • Muhlestein J.B.
        • Intermountain Heart Collaborative Study Group
        Frequency of elevation of C-reactive protein in atrial fibrillation.
        Am J Cardiol. 2004; 94: 1255-1259
        • Aviles R.J.
        • Martin D.O.
        • Apperson-Hansen C.
        • Houghtaling P.L.
        • Rautaharju P.
        • Kronmal R.A.
        • Tracy R.P.
        • Van Wagoner D.R.
        • Psaty B.M.
        • Lauer M.S.
        • Chung M.K.
        Inflammation as a risk factor for atrial fibrillation.
        Circulation. 2003; 108: 3006-3010
        • Abdelhadi R.H.
        • Gurm H.S.
        • Van Wagoner D.R.
        • Chung M.K.
        Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively.
        Am J Cardiol. 2004; 93: 1176-1178
        • Horne B.D.
        • Anderson J.L.
        • John J.M.
        • Weaver A.
        • Bair T.L.
        • Jensen K.R.
        • Renlund D.G.
        • Muhlestein J.B.
        • Intermountain Heart Collaborative Study Group
        Which white blood cell subtypes predict increased cardiovascular risk?.
        J Am Coll Cardiol. 2005; 45: 1638-1643
        • Duffy B.K.
        • Gurm H.S.
        • Rajagopal V.
        • Gupta R.
        • Ellis S.G.
        • Bhatt D.L.
        Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention.
        Am J Cardiol. 2006; 97: 993-996
        • Papa A.
        • Emdin M.
        • Passino C.
        • Michelassi C.
        • Battaglia D.
        • Cocci F.
        Predictive value of elevated neutrophil–lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease.
        Clin Chim Acta. 2008; 395: 27-31
        • Tamhane U.U.
        • Aneja S.
        • Montgomery D.
        • Rogers E.-K.
        • Eagle K.A.
        • Gurm H.S.
        Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome.
        Am J Cardiol. 2008; 102: 653-657
        • Nunez J.
        • Nunez E.
        • Bodi V.
        • Sanchis J.
        • Minana G.
        • Mainar L.
        • Santas E.
        • Merlos P.
        • Rumiz E.
        • Darmofal H.
        • Heatta A.
        • Llacer A.
        Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction.
        Am J Cardiol. 2008; 101: 747-752
        • Gibson P.H.
        • Croal B.L.
        • Cuthbertson B.H.
        • Small G.R.
        • Ifezulike A.I.
        • Gibson G.
        • Jeffrey R.R.
        • Buchan K.G.
        • El-Shafei H.
        • Hillis G.S.
        Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting.
        Am Heart J. 2007; 154: 995-1002
        • National Kidney Foundation
        K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.
        Am J Kidney Dis. 2002; 39: S1-S266
        • Lo B.
        • Fijnheer R.
        • Nierich A.P.
        • Bruins P.
        • Kalkman C.J.
        C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization.
        Ann Thorac Surg. 2005; 79: 1530-1535
        • Lamm G.
        • Auer J.
        • Weber T.
        • Berent R.
        • Ng C.
        • Eber B.
        Postoperative white blood cell count predicts atrial fibrillation after cardiac surgery.
        J Cardiothorac Vasc Anesth. 2006; 20: 51-56
        • Coller B.S.
        Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene?.
        Arterioscler Thromb Vasc Biol. 2005; 25: 658-670
        • Madjid M.
        • Awan I.
        • Willerson J.T.
        • Casscells S.W.
        Leukocyte count and coronary heart disease: implications for risk assessment.
        J Am Coll Cardiol. 2004; 44: 1945-1956
        • Ramlawi B.
        • Otu H.
        • Mieno S.
        • Boodhwani M.
        • Sodha N.R.
        • Clements R.T.
        • Bianchi C.
        • Sellke F.W.
        Oxidative stress and atrial fibrillation after cardiac surgery: a case-control study.
        Ann Thorac Surg. 2007; 84: 1166-1172
        • Fontes M.L.
        • Mathew J.P.
        • Rinder H.M.
        • Zelterman D.
        • Smith B.R.
        • Rinder C.S.
        • Multicenter Study of Perioperative Ischemia (McSPI) Research Group
        Atrial fibrillation after cardiac surgery/cardiopulmonary bypass is associated with monocyte activation.
        Anesth Analg. 2005; 101: 17-23
        • Ucar H.I.
        • Tok M.
        • Atalar E.
        • Dogan O.F.
        • Oc M.
        • Farsak B.
        • Guvener M.
        • Yilmaz M.
        • Dogan R.
        • Demircin M.
        • Pasaoglu I.
        Predictive significance of plasma levels of interleukin-6 and high-sensitivity C-reactive protein in atrial fibrillation after coronary artery bypass surgery.
        Heart Surg Forum. 2007; 10: E131-E135
        • Ahlsson A.J.
        • Bodin L.
        • Lundblad O.H.
        • Englund A.G.
        Postoperative atrial fibrillation is not correlated to C-reactive protein.
        Ann J Thorac Surg. 2007; 83: 1332-1337
        • Gasz B.
        • Lenard L.
        • Benko L.
        • Borsiczky B.
        • Szanto Z.
        • Lantos J.
        • Szabados S.
        • Alotti N.
        • Papp L.
        • Roth E.
        Expression of CD97 and adhesion molecules on circulating leukocytes in patients undergoing coronary artery bypass surgery.
        Eur Surg Res. 2005; 37: 281-289
        • Ommen S.R.
        • Gibbons R.J.
        • Hodge D.O.
        • Thomson S.P.
        Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease.
        Am J Cardiol. 1997; 79: 812-814
        • Ommen S.R.
        • Hodge D.O.
        • Rodeheffer R.J.
        • McGregor C.G.
        • Thomson S.P.
        • Gibbons R.J.
        Predictive power of the relative lymphocyte concentration in patients with advanced heart failure.
        Circulation. 1998; 97: 19-22